Recent Developments and Current Controversies in Depression

K. P. Ebmeier, C. Donaghey, John Douglas Steele

    Research output: Contribution to journalArticle

    283 Citations (Scopus)

    Abstract

    In this review of the last 5 years' developments in research into depression we focus on recent advances and current controversies. We cover epidemiology and basic science as well as the treatment of depression in adults in all its forms. Depression in childhood and adolescence, as well as in old age has been covered in recent Seminars in The Lancet. Depression in adulthood remains a very common and under-treated condition, resulting in a high degree of disability. Increasingly detailed knowledge about impairment of information processing in depression is being supplemented by quantitative studies of the brain processes underlying these impairments. Most patients improve with present treatments. The mechanisms of action of antidepressants are not fully understood; the hypothesis that reversing hippocampal cell loss in depression may be their active principle is a fascinating new development. Moral panic about the claim that antidepressant serotonin reuptake inhibitors cause patients to commit suicide and become addicted to their medication may have disconcerted the public and members of the medical profession. We will try to describe the considerable effort that has gone into collecting evidence to enlighten this debate.

    Original languageEnglish
    Pages (from-to)153-167
    Number of pages14
    JournalThe Lancet
    Volume367
    Publication statusPublished - 2006

    Keywords

    • TRANSCRANIAL MAGNETIC STIMULATION
    • SEROTONIN REUPTAKE INHIBITORS
    • TREATMENT-RESISTANT DEPRESSION
    • RANDOMIZED CONTROLLED-TRIAL
    • POSTTRAUMATIC-STRESS-DISORDER
    • OBSESSIVE-COMPULSIVE-DISORDER
    • RECURRENT MAJOR DEPRESSION
    • FACTOR GENETIC-POLYMORPHISM
    • LEFT PREFRONTAL ACTIVATION
    • PROBLEM-SOLVING TREATMENT

    Cite this

    Ebmeier, K. P., Donaghey, C., & Steele, J. D. (2006). Recent Developments and Current Controversies in Depression. The Lancet, 367, 153-167.

    Recent Developments and Current Controversies in Depression. / Ebmeier, K. P.; Donaghey, C.; Steele, John Douglas.

    In: The Lancet, Vol. 367, 2006, p. 153-167.

    Research output: Contribution to journalArticle

    Ebmeier, KP, Donaghey, C & Steele, JD 2006, 'Recent Developments and Current Controversies in Depression', The Lancet, vol. 367, pp. 153-167.
    Ebmeier KP, Donaghey C, Steele JD. Recent Developments and Current Controversies in Depression. The Lancet. 2006;367:153-167.
    Ebmeier, K. P. ; Donaghey, C. ; Steele, John Douglas. / Recent Developments and Current Controversies in Depression. In: The Lancet. 2006 ; Vol. 367. pp. 153-167.
    @article{33d3c3414f604d139c6c56925dfd3eda,
    title = "Recent Developments and Current Controversies in Depression",
    abstract = "In this review of the last 5 years' developments in research into depression we focus on recent advances and current controversies. We cover epidemiology and basic science as well as the treatment of depression in adults in all its forms. Depression in childhood and adolescence, as well as in old age has been covered in recent Seminars in The Lancet. Depression in adulthood remains a very common and under-treated condition, resulting in a high degree of disability. Increasingly detailed knowledge about impairment of information processing in depression is being supplemented by quantitative studies of the brain processes underlying these impairments. Most patients improve with present treatments. The mechanisms of action of antidepressants are not fully understood; the hypothesis that reversing hippocampal cell loss in depression may be their active principle is a fascinating new development. Moral panic about the claim that antidepressant serotonin reuptake inhibitors cause patients to commit suicide and become addicted to their medication may have disconcerted the public and members of the medical profession. We will try to describe the considerable effort that has gone into collecting evidence to enlighten this debate.",
    keywords = "TRANSCRANIAL MAGNETIC STIMULATION, SEROTONIN REUPTAKE INHIBITORS, TREATMENT-RESISTANT DEPRESSION, RANDOMIZED CONTROLLED-TRIAL, POSTTRAUMATIC-STRESS-DISORDER, OBSESSIVE-COMPULSIVE-DISORDER, RECURRENT MAJOR DEPRESSION, FACTOR GENETIC-POLYMORPHISM, LEFT PREFRONTAL ACTIVATION, PROBLEM-SOLVING TREATMENT",
    author = "Ebmeier, {K. P.} and C. Donaghey and Steele, {John Douglas}",
    year = "2006",
    language = "English",
    volume = "367",
    pages = "153--167",
    journal = "The Lancet",
    issn = "0140-6736",
    publisher = "ACADEMIC PRESS INC ELSEVIER SCIENCE",

    }

    TY - JOUR

    T1 - Recent Developments and Current Controversies in Depression

    AU - Ebmeier, K. P.

    AU - Donaghey, C.

    AU - Steele, John Douglas

    PY - 2006

    Y1 - 2006

    N2 - In this review of the last 5 years' developments in research into depression we focus on recent advances and current controversies. We cover epidemiology and basic science as well as the treatment of depression in adults in all its forms. Depression in childhood and adolescence, as well as in old age has been covered in recent Seminars in The Lancet. Depression in adulthood remains a very common and under-treated condition, resulting in a high degree of disability. Increasingly detailed knowledge about impairment of information processing in depression is being supplemented by quantitative studies of the brain processes underlying these impairments. Most patients improve with present treatments. The mechanisms of action of antidepressants are not fully understood; the hypothesis that reversing hippocampal cell loss in depression may be their active principle is a fascinating new development. Moral panic about the claim that antidepressant serotonin reuptake inhibitors cause patients to commit suicide and become addicted to their medication may have disconcerted the public and members of the medical profession. We will try to describe the considerable effort that has gone into collecting evidence to enlighten this debate.

    AB - In this review of the last 5 years' developments in research into depression we focus on recent advances and current controversies. We cover epidemiology and basic science as well as the treatment of depression in adults in all its forms. Depression in childhood and adolescence, as well as in old age has been covered in recent Seminars in The Lancet. Depression in adulthood remains a very common and under-treated condition, resulting in a high degree of disability. Increasingly detailed knowledge about impairment of information processing in depression is being supplemented by quantitative studies of the brain processes underlying these impairments. Most patients improve with present treatments. The mechanisms of action of antidepressants are not fully understood; the hypothesis that reversing hippocampal cell loss in depression may be their active principle is a fascinating new development. Moral panic about the claim that antidepressant serotonin reuptake inhibitors cause patients to commit suicide and become addicted to their medication may have disconcerted the public and members of the medical profession. We will try to describe the considerable effort that has gone into collecting evidence to enlighten this debate.

    KW - TRANSCRANIAL MAGNETIC STIMULATION

    KW - SEROTONIN REUPTAKE INHIBITORS

    KW - TREATMENT-RESISTANT DEPRESSION

    KW - RANDOMIZED CONTROLLED-TRIAL

    KW - POSTTRAUMATIC-STRESS-DISORDER

    KW - OBSESSIVE-COMPULSIVE-DISORDER

    KW - RECURRENT MAJOR DEPRESSION

    KW - FACTOR GENETIC-POLYMORPHISM

    KW - LEFT PREFRONTAL ACTIVATION

    KW - PROBLEM-SOLVING TREATMENT

    M3 - Article

    VL - 367

    SP - 153

    EP - 167

    JO - The Lancet

    JF - The Lancet

    SN - 0140-6736

    ER -